M L Bots, F van Kooten, M M Breteler, P E Slagboom, A Hofman, F Haverkate, P Meijer, P J Koudstaal, D E Grobbee, C Kluft
{"title":"痴呆患者和非痴呆患者对活化蛋白C的反应。荷兰痴呆研究中的血管因素。","authors":"M L Bots, F van Kooten, M M Breteler, P E Slagboom, A Hofman, F Haverkate, P Meijer, P J Koudstaal, D E Grobbee, C Kluft","doi":"10.1159/000022432","DOIUrl":null,"url":null,"abstract":"<p><p>We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.</p>","PeriodicalId":12910,"journal":{"name":"Haemostasis","volume":"28 3-4","pages":"209-15"},"PeriodicalIF":0.0000,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000022432","citationCount":"19","resultStr":"{\"title\":\"Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.\",\"authors\":\"M L Bots, F van Kooten, M M Breteler, P E Slagboom, A Hofman, F Haverkate, P Meijer, P J Koudstaal, D E Grobbee, C Kluft\",\"doi\":\"10.1159/000022432\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.</p>\",\"PeriodicalId\":12910,\"journal\":{\"name\":\"Haemostasis\",\"volume\":\"28 3-4\",\"pages\":\"209-15\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000022432\",\"citationCount\":\"19\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haemostasis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000022432\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemostasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000022432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19
摘要
我们对295名痴呆患者和406名对照患者进行了横断病例对照研究,这些患者来自鹿特丹研究的参与者,鹿特丹研究是一项年龄在55岁或以上的人群队列研究,以及鹿特丹卒中数据库(一个基于医院的卒中登记处)的参与者,以评估因子V Leiden突变和活化蛋白C (APC)反应与痴呆及其亚型的关系。与缺乏因子V Leiden突变的受试者相比,因子V Leiden突变携带者患痴呆的风险增加了2.11倍(95%可信区间,CI, 0.93-4.77)。血管性痴呆和阿尔茨海默病的风险分别增加4.28 (95% CI 1.26-14.5)和2.15 (95% CI 0.82-5.63)。APC反应未发现关联。我们发现,在Leiden因子V的受试者中,痴呆的风险增加了两倍。这种关联在血管性痴呆中似乎更强。
Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.
We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.